{"task_id": "f2a4a0489afa7f2b", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 363/464)", "text": "(CONT\u2019D)\nPATHOPHYSIOLOGY (CONT\u2019D)\n354\nOsteoporosis\n\n--- Page 376 ---\nCLINICAL FEATURES (CONT\u2019D)\nLR+\nLR\nDecision Rules\nSimple calculated osteoporosis risk\nestimation (score \u00046)\n1.2\n0.02\nOsteoporosis risk assessment\ninstrument (score \u00049)\n1.4\n0.1\nNational osteoporosis foundation\n(score \u00041)\n1.2\n0.2\nAge/body size/no estrogen (score\n\u00042)\n1.6\n0.3\nAPPROACH\n\u2018no single physical examination find\ning or combination of findings is sufficient to rule in\nosteoporosis or spinal fracture without further test\ning. Several convenient examination maneuvers\nincluding low body weight (<51 kg [<112 lb]), in\nability to place the back of the head against a wall\nwhen standing upright, low tooth count, self\nreported humped back, and rib pelvis distance can\nsignificantly increase the likelihood of osteoporosis\nor spinal fracture and identify additional women\nwho would benefit from earlier screening\u2019\nJAMA 2004 292:23\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCa, PO4, albumin, 25 OH vitamin D, PTH,\nALP, CBC, serum protein electrophoresis, TSH\n\u0002\nIMAGING\nbone density scan (dual energy X ray\nabsorptiometry, DEXA), spine XR\nDIAGNOSTIC AND PROGNOSTIC ISSUES\nOSTEOPOROSIS RISK ASSESSMENT INSTRUMENT\n\u0002\nSCORING\nage 55 64 (+5), age 65 74 (+10), >75\n(+10), weight 60 70 kg (+3), <60 kg (+9), not\ncurrently on estrogen (+2)\n\u0002\nUTILITY\nconsider bone density if score \u00049 points\nin postmenopausal women (sens=94.2% for T\nscore < 2.0, spc=43.7% for T score > 1)>\nWHO SHOULD BE SCREENED WITH DEXA?\nCanadian guidelines suggest testing if personal his\ntory of fragility fracture after age 40 or any clinical risk\nfactors (1 major or 2 minor)\n\u0002\nMAJOR\nage >65, vertebral fracture, family his\ntory,\nsystemic\nglucocorticoid\ntreatment\n>3\nmonths, malabsorption syndrome, primary hyper\nparathyroidism, propensity to fall, osteopenia\napparent on X ray, hypogonadism, early meno\npause age <45\n\u0002\nMINOR\nrheumatoid\narthritis,\nhyperthyroidism,\nchronic anticonvulsant treatment, low dietary cal\ncium, smoker, excessive alcohol, excessive caf\nfeine, weight <57 kg [<126 lb], weight loss\n>10% of weight at 25 years, chronic heparin\ntreatment\nDIAGNOSTIC AND PROGNOSTIC ISSUES (CONT\u2019D)\nPROGNOSIS\nan average 50 year old Caucasian\nwoman has a remaining lifetime risk of 40% of devel\noping hip, vertebra, or wrist fractures\nMANAGEMENT\nLIFESTYLE CHANGES\nCaCO3 500 mg PO TID. Vita\nmin D 800 IU PO daily. Physical activity >30 min\n3\u0003/week. Avoid excess caffeine (>4 cups/day) and\navoid dietary Na (>2100 mg/day)\nMEDICATIONS\nbisphosphonates (patients over\nthe age of 50 should be stratified as to their 10 year\nfracture risk. Patients who are at high risk of having a\nfracture in the next 10 years should be started on\nbisphosphonates. Bisphosphonates should be taken\nwith water >60 min before first meal, and remain\nupright \u000330 min. Alendronate 70 mg PO weekly,\nrisedronate 35 mg PO weekly, etidronate/Didrocal kit\n1 tablet/day). Duration of therapy is controversial\n(e.g. 5 10 years, with possibly \u2018\u2018drug holiday\u2019\u2019 for\n1 5 years between treatment courses). SERM (ralox\nifene 60 mg PO daily). hPTH(1 34) (first line for\ntreatment if severe osteoporosis). Calcitonin (second\nline for prevention, first line for pain. Calcitonin nasal\nspray 200 IU NAS daily alternate nostrils). Hormone\nreplacement (no longer used in osteoporosis, used\nonly for control of hot flashes)\nTREATMENT ISSUES\nWHO SHOULD BE TREATED?\n\u0002\nIF\b2.5 <BMD< 1.5 plus any one of following:\npersonal history of fragility fracture after age 40,\nnon traumatic vertebral deformities, or clinical risk\nfactors (1 major or 2 minor)\nlifestyle D +\nmedications\n\u0002\nIF BMD < 2.5\nlifestyle D + medications\nFRACTURE INDEX FOR POSTMENOPAUSAL WOMEN\n\u0002\nSCORING\nage 65 69 (+1), age 70 74 (+2), age\n75 79 (+3), age 80 84 (+4), age >85 (+5), history\nof any fracture after 50 years of age (+1), mother\nhad hip fracture after 50 years of age (+1), weight\n<57 kg [<126 lb] (+1), current smoker (+1), uses\narms to assist in standing from a chair (+2), total\nhip T score\n1 to\n2 SD (+2),\n2 to\n2.5 SD (+3),\n< 2.5 SD (+4)\n\u0002 5-YEAR FRACTURE RISK\nfor vertebral, non vertebral\nand hip fractures, score 1 2=1.2, 9.6, 0.4%, respec\ntively. Score 3 4=2.5, 13.1, 0.9%. Score 5=5.3,\n16.5, 1.9%. Score 6 7=7.1, 19.8, 3.9%. Score\n8 13=11.2, 27.5, 8.7%. A score of 4 or greater war\nrants treatment\nSPECIFIC ENTITIES\nPAGET\u2019S DISEASE OF BONE\n\u0002\nPATHOPHYSIOLOGY\naggressive bone resorption by\nosteoclasts (skull, pelvis, vertebra, femur, tibia) that\nOsteoporosis\n355", "text_length": 4414, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 363/464)", "type": "chunk", "chunk_index": 362, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.749322", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.750089", "status": "complete", "chunks_added": 3}